This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (87)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Cognitive Disorders  • Alert me on articles by topic

Angela L. Guillozet, PhD; Sandra Weintraub, PhD; Deborah C. Mash, PhD; M. Marsel Mesulam, MD

Arch Neurol. 2003;60:729-736.

Background  Large numbers of neurofibrillary tangles (NFTs) and amyloid plaques are diagnostic markers for Alzheimer disease (AD), but lesser numbers of these lesions are also seen in nondemented elderly individuals. Much of the existing literature suggests that the NFTs of AD have a closer correlation with cognitive function than do amyloid plaques. Whether a similar relationship exists in normal aging and mild cognitive impairment (MCI), a condition that frequently reflects a preclinical stage of AD, remains unknown.

Objective  To determine the distribution patterns of -amyloid plaques and NFTs and the association of these lesions with memory performance in nondemented individuals.

Methods  We investigated regional distributions and neuropsychological correlates of NFTs and amyloid plaques in cognitively normal elderly persons and subjects with MCI who received neuropsychological testing before death.

Subjects  Eight nondemented subjects who volunteered to receive annual neuropsychological testing and agreed to brain donation were studied. Five subjects showed no cognitive impairment, and 3 were diagnosed with MCI.

Results  Distribution of NFTs followed a rigorous and hierarchical pattern, but distribution of amyloid plaques varied among individuals. Subjects with MCI displayed higher NFT densities than did nonimpaired subjects. In addition, NFT density in the temporal lobe correlated with memory scores, whereas density of amyloid plaques did not.

Conclusions  Neurofibrillary tangles are more numerous in medial temporal lobe regions associated with memory function and show a relationship to performance on memory tests in nondemented individuals. These results suggest that NFTs may constitute a pathological substrate for memory loss not only in AD but also in normal aging and MCI.

From the Cognitive Neurology and Alzheimer's Disease Center, Northwestern University, Chicago, Ill (Drs Guillozet, Weintraub, and Mesulam); and the Department of Neurology, University of Miami School of Medicine, Miami, Fla (Dr Mash).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Physical frailty in older persons is associated with Alzheimer disease pathology
Buchman et al.
Neurology 2008;71:499-504.
ABSTRACT | FULL TEXT  

Morphometric Changes in the Episodic Memory Network and Tau Pathologic Features Correlate with Memory Performance in Patients with Mild Cognitive Impairment
Fjell et al.
Am. J. Neuroradiol. 2008;29:1183-1189.
ABSTRACT | FULL TEXT  

Facial Emotion Recognition Deficit in Amnestic Mild Cognitive Impairment and Alzheimer Disease
Spoletini et al.
AJGP 2008;16:389-398.
ABSTRACT | FULL TEXT  

Change in Depressive Symptoms During the Prodromal Phase of Alzheimer Disease
Wilson et al.
Arch Gen Psychiatry 2008;65:439-445.
ABSTRACT | FULL TEXT  

{beta}-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
Pike et al.
Brain 2007;130:2837-2844.
ABSTRACT | FULL TEXT  

Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
Cummings et al.
Neurology 2007;69:1622-1634.
ABSTRACT | FULL TEXT  

Olfactory Identification and Incidence of Mild Cognitive Impairment in Older Age
Wilson et al.
Arch Gen Psychiatry 2007;64:802-808.
ABSTRACT | FULL TEXT  

Chronic distress and incidence of mild cognitive impairment
Wilson et al.
Neurology 2007;68:2085-2092.
ABSTRACT | FULL TEXT  

Amyloid-beta in Alzheimer Disease: The Null versus the Alternate Hypotheses
Lee et al.
J. Pharmacol. Exp. Ther. 2007;321:823-829.
ABSTRACT | FULL TEXT  

Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff et al.
Neurology 2007;68:1501-1508.
ABSTRACT | FULL TEXT  

Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy
Berger et al.
J. Neurosci. 2007;27:3650-3662.
ABSTRACT | FULL TEXT  

Active {beta}-Amyloid Immunization Restores Spatial Learning in PDAPP Mice Displaying Very Low Levels of {beta}-Amyloid
Chen et al.
J. Neurosci. 2007;27:2654-2662.
ABSTRACT | FULL TEXT  

Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis
Forman et al.
Neurology 2007;68:757-763.
ABSTRACT | FULL TEXT  

Progranulin Mutations in Primary Progressive Aphasia: The PPA1 and PPA3 Families
Mesulam et al.
Arch Neurol 2007;64:43-47.
ABSTRACT | FULL TEXT  

Pathologic and Nicotinic Receptor Binding Differences Between Mild Cognitive Impairment, Alzheimer Disease, and Normal Aging
Sabbagh et al.
Arch Neurol 2006;63:1771-1776.
ABSTRACT | FULL TEXT  

Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects.
Hodges
Brain 2006;129:2811-2822.
ABSTRACT | FULL TEXT  

Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease
Singh et al.
Brain 2006;129:2885-2893.
ABSTRACT | FULL TEXT  

Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett et al.
Neurology 2006;66:1837-1844.
ABSTRACT | FULL TEXT  

Neuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen et al.
Arch Neurol 2006;63:665-672.
ABSTRACT | FULL TEXT  

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha et al.
Arch Neurol 2006;63:674-681.
ABSTRACT | FULL TEXT  

Glia as a Therapeutic Target: Selective Suppression of Human Amyloid-beta-Induced Upregulation of Brain Proinflammatory Cytokine Production Attenuates Neurodegeneration
Ranaivo et al.
J. Neurosci. 2006;26:662-670.
ABSTRACT | FULL TEXT  

Neuropathologic Substrate of Mild Cognitive Impairment
Markesbery et al.
Arch Neurol 2006;63:38-46.
ABSTRACT | FULL TEXT  

Soluble {beta}-Amyloid1-40 Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses
Roselli et al.
J. Neurosci. 2005;25:11061-11070.
ABSTRACT | FULL TEXT  

Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz et al.
Science 2005;309:476-481.
ABSTRACT | FULL TEXT  

Cognitive aging and Alzheimer's disease
Vandenberghe and Tournoy
Postgrad. Med. J. 2005;81:343-352.
ABSTRACT | FULL TEXT  

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
Bennett et al.
Neurology 2005;64:834-841.
ABSTRACT | FULL TEXT  

Staying Connected: Synapses in Alzheimer Disease
Lee et al.
Am. J. Pathol. 2004;165:1461-1464.
FULL TEXT  

Stroke risk factors and loss of high cognitive function
Elkins et al.
Neurology 2004;63:793-799.
ABSTRACT | FULL TEXT  

Cerebrospinal Fluid Tau Protein and Periventricular White Matter Lesions in Patients With Mild Cognitive Impairment: Implications for 2 Major Pathways
Maruyama et al.
Arch Neurol 2004;61:716-720.
ABSTRACT | FULL TEXT  

Early A{beta} accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
Ingelsson et al.
Neurology 2004;62:925-931.
ABSTRACT | FULL TEXT  

Shrinkage of the Entorhinal Cortex over Five Years Predicts Memory Performance in Healthy Adults
Rodrigue and Raz
J. Neurosci. 2004;24:956-963.
ABSTRACT | FULL TEXT